Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were in short supply. Novo Nordisk, the manufacturer of NovoLog, also reported periodic shortages this year. The company said ...
NovoLog (insulin aspart) is a brand-name injectable solution that’s prescribed for type 1 and type 2 diabetes. NovoLog has interactions with alcohol, some other drugs, and certain supplements.
The company discontinued its 3-milliliter vials of Humalog, which is mainly used ... Earlier this year, the drugmaker reported shortages of NovoLog insulin. Patients with Type 1 diabetes must ...